Oftan (Timolol)

Timolol blocks β‑adrenergic receptors in the ciliary body, reducing the production of aqueous humor. This decrease in fluid formation lowers intra‑ocular pressure, which is essential in managing glaucoma and ocular hypertension.

The prescribed dose of Oftan is determined by the treating ophthalmologist based on the patient’s condition and response. Typically, one drop is instilled in the affected eye(s) once or twice daily, but the exact regimen must follow the prescriber’s instructions.

Safety data for timolol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Oftan, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oftan (timolol) is a non‑selective beta‑blocker, whereas many alternatives are prostaglandin analogues or carbon‑ic anhydrase inhibitors. Timolol primarily reduces aqueous humor production, while prostaglandins increase outflow. Choice of therapy depends on efficacy, tolerance, patient comorbidities and physician preference.

Oftan should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and discard any solution that appears discolored or contains particles.

Oftan is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few minutes.

Serious risks include systemic bradycardia, hypotension, bronchospasm in susceptible individuals, and severe allergic reactions such as angio‑edema. Patients should seek immediate medical attention if they experience chest pain, difficulty breathing, rapid weight gain, or signs of an allergic reaction.

Oftan is contraindicated in patients with known hypersensitivity to timolol or other beta‑blockers, those with severe sinus bradycardia, second‑ or third‑degree heart block, decompensated heart failure, or uncontrolled asthma/COPD. A healthcare professional should evaluate suitability before prescribing.